EUVIMEDEUVIMED entdecken
VergleichsstudieKohortenstudieOpen Access · CC BY-NC-ND 4.0

Tranexamic acid is associated with post‐injury mortality in a resource‐limited trauma system: Findings from the epidemiology and outcomes of prolonged trauma care cohort study

Adane F Wogu iD, Julia M Dixon, Mengli Xiao, Hendrick J Lategan, George Oosthuizen, Steven G Schauer iD, Elmin Steyn, Smitha Bhaumik, Janette Verster, Craig Wylie, Shaheem de Vries, Mohammad Mayet iD und 10 weitere

Transfusion · 2025

DOI: 10.1111/trf.18171 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Transfusion, 2025. Verfasst von Adane F Wogu und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics and Informatics, Colorado School of Public Health, Anschutz Medical Campus, Colorado, Aurora, USA. Hauptthemen laut MEDLINE: Antifibrinolytic Agents, Hemorrhage, Tranexamic Acid, Wounds and Injuries. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: U.S. Department of Defense.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Injury‐related deaths claim millions of lives annually, with severe hemorrhage a leading cause. This study assesses tranexamic acid (TXA) administered within 3 h post‐injury on mortality in trauma patients. Study Design And Methods We conducted secondary database analysis of EpiC, a multicenter, prospective cohort of trauma patients in South Africa. We compared mortality between severely injured patients at risk for traumatic hemorrhage receiving TXA within 3 h post‐injury versus untreated patients. Inverse probability of treatment weighting adjusted for confounders, and multivariate logistic regression assessed 24‐h mortality, with extended secondary outcome analyses.

Results

Of 3607 analyzed patients, 502 received TXA within 3 h. TXA reduced 24‐h mortality by 38% (marginal odds ratio [mOR], 0.62; 95% confidence interval [CI], 0.49–0.78) versus untreated patients. Similar reductions were observed for longer‐term mortality. Subgroup analyses revealed reduced mortality when TXA was given within 2 h post‐injury (mOR, 0.57; 95% CI, 0.45–0.73), doses of 1 g of TXA within 3 h (mOR, 0.73; 95% CI, 0.56–0.94), and those with the highest risk of hemorrhage (mOR, 0.40; 95% CI, 0.30–0.53). The 24‐h mortality reduction was significant for patients with penetrating injury (mOR, 0.58; 95% CI, 0.43–0.78) but not for blunt injury patients. Sensitivity analyses confirmed the robustness of these findings, with TXA consistently reducing mortality odds by 28%–39% across subgroups.

Discussion

Early TXA administration significantly reduced mortality in trauma patients, especially with penetrating injuries and those with the highest risk of hemorrhage. One‐gram dosing was as effective as higher doses, and mortality reduction was notable when TXA was given within 2 h post‐injury. These findings support TXA use in resource‐limited trauma protocols.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifibrinolytic AgentsHemorrhageTranexamic AcidWounds and InjuriesAdultFemaleHumansMaleMiddle AgedCohort StudiesProspective StudiesSouth AfricaTrauma CentersObservational Studies as TopicMulticenter Studies as TopicSecondary Data Analysis

Stichwörter der Autor:innen

emergency medicineglobal healthhemorrhagemilitary medicinetranexamic acidtrauma

Substanzen

Antifibrinolytic AgentsTranexamic Acid

Autor:innen und Institutionen

  • Department of Biostatistics and Informatics, Colorado School of Public Health, Anschutz Medical Campus, Colorado, Aurora, USA.
  • Department of Emergency Medicine, University of Colorado, School of Medicine, Anschutz Medical Campus, Colorado, Aurora, USA.
  • Division of Surgery, Department of Surgical Sciences, Stellenbosch University, Cape Town, South Africa.
  • Department of Anesthesiology, University of Colorado, School of Medicine, Anschutz Medical Campus, Colorado, Aurora, USA.
  • Division of Forensic Medicine, Department of Pathology, Stellenbosch University, Cape Town, South Africa.
  • Emergency Medical Services, Western Cape Government Health and Wellness, Cape Town, South Africa.

ORCID-Profile: Adane F Wogu, Steven G Schauer, Mohammad Mayet, Nee-Kofi Mould-Millman

Förderung

  • U.S. Department of Defense

Zitieren

APA

Wogu, A. F., Dixon, J. M., Xiao, M., Lategan, H. J., Oosthuizen, G., Schauer, S. G., Steyn, E., Bhaumik, S., Verster, J., Wylie, C., de Vries, S., Mayet, M., Hodsdon, L., Wagner, L., Snyders, L. O., Doubell, K., Lourens, D., Stassen, W., Rees, C., …, & Mould-Millman, N. K. (2025). Tranexamic acid is associated with post‐injury mortality in a resource‐limited trauma system: Findings from the epidemiology and outcomes of prolonged trauma care cohort study. Transfusion. https://doi.org/10.1111/trf.18171

Vancouver

Wogu AF, Dixon JM, Xiao M, Lategan HJ, Oosthuizen G, Schauer SG, et al. Tranexamic acid is associated with post‐injury mortality in a resource‐limited trauma system: Findings from the epidemiology and outcomes of prolonged trauma care cohort study. Transfusion. 2025. doi:10.1111/trf.18171

BibTeX
@article{Wogu2025,
  author = {Wogu, Adane F and Dixon, Julia M and Xiao, Mengli and Lategan, Hendrick J and Oosthuizen, George and Schauer, Steven G and Steyn, Elmin and Bhaumik, Smitha and Verster, Janette and Wylie, Craig and de Vries, Shaheem and Mayet, Mohammad and Hodsdon, Lesley and Wagner, Leigh and Snyders, L' Oreal and Doubell, Karlien and Lourens, Denise and Stassen, Willem and Rees, Christiaan and Young, Jessica and Moore, Ernest E and Mould-Millman, Nee-Kofi},
  title = {Tranexamic acid is associated with post‐injury mortality in a resource‐limited trauma system: Findings from the epidemiology and outcomes of prolonged trauma care cohort study},
  journal = {Transfusion},
  year = {2025},
  doi = {10.1111/trf.18171}
}
Kostenlos starten →